SCHEMBL30131228

SCHEMBL30131228

Cc1ccccc1S(=O)(O)=S

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYC P01106 1/20 0.41
HSD11B1 P28845 1/20 0.41
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
ESR1 P03372 2/20 0.40
ESR2 Q92731 2/20 0.40
GAA P10253 1/20 0.40
KEAP1 Q14145 1/20 0.40
NFE2L2 Q16236 1/20 0.40
SLC1A3 P43003 1/20 0.40
SLC1A2 P43004 1/20 0.40
SLC1A1 P43005 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
RAPGEF4 Q8WZA2 1/20 0.40
TSHR P16473 1/20 0.39
ACHE P22303 1/20 0.39
KAT6A Q92794 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5166438 1.00 MYC (0.41) MYCHSD11B1KMT2AMEN1ESR1
SCHEMBL9462168 0.98 HSD11B1 (0.44) MYCHSD11B1KMT2AMEN1ESR1
SCHEMBL8417858 0.87 MAPT (0.37) MYCHSD11B1KMT2AMEN1ESR1
SCHEMBL1748 0.81 MYC (0.53) MYCHSD11B1KMT2AMEN1ESR1
SCHEMBL29392580 0.81 MYC (0.53) MYCHSD11B1KMT2AMEN1ESR1
SCHEMBL15670401 0.81 ALDH1A1 (0.50) MYCKMT2AMEN1ESR1ESR2
Ammonia Solution, Strong SCHEMBL6360239 0.79 MYC (0.52) MYCHSD11B1KMT2AMEN1ESR1
SCHEMBL6916771 0.79 MYC (0.52) MYCHSD11B1KMT2AMEN1ESR1
SCHEMBL8715920 0.79 MYC (0.52) MYCHSD11B1KMT2AMEN1ESR1
Water SCHEMBL3917281 0.79 MYC (0.52) MYCHSD11B1KMT2AMEN1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240229026-A1 CHIRAL CONTROL WAVE LIFE SCIENCES LTD. (SG) 2024-07-11 US disclosed
US-11643657-B2 Chiral control WAVE LIFE SCIENCES LTD. (SG) 2023-05-09 US disclosed
EP-2872147-B1 METHOD FOR MAKING CHIRAL OLIGONUCLEOTIDES WAVE LIFE SCIENCES LTD (SG) 2022-12-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240229026-A1 CHIRAL CONTROL RNGTT, POLI, NSUN3 MYC 2279/4885HSD11B1 3302/4885KMT2A 2211/4885
US-11643657-B2 Chiral control RNGTT, POLI, NSUN3 MYC 2279/4885HSD11B1 3302/4885KMT2A 2211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.